AWARD-9 (GBDI Study)

• Research type

  Research Study

• Full title

  A Randomized, Double-Blind Trial Comparing the Effect of Dulaglutide 1.5 mg with Placebo on Glycemic Control in Patients with Type 2 Diabetes on Basal Insulin Glargine (AWARD-9: Assessment of Weekly AdministRation of LY2189265 in Diabetes - 9)

• IRAS ID

  150119

• Contact name

  David Russell Jones

• Contact email

  davidrussell-jones@nhs.net

• Sponsor organisation

  Eli Lilly and Company

• Eudract number

  2012-004229-25

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  14/SC/0185

• Date of REC Opinion

  22 Apr 2014

• REC opinion

  Further Information Favourable Opinion